| TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma (NCT01605734) | Shandong Cancer Hospital and Institute | 2012-07-01 |
| Lenalidomide in Relapsed or Refractory Primary-cutaneous Large B-cell Lymphoma Leg-type : Multicentre Prospective Phase II Single Arm Trial of the French Study Group of Cutaneous Lymphoma (NCT01556035) | University Hospital, Bordeaux | 2012-07-01 |
| The Use of Ketorolac in Surgical Neonates (NCT01667120) | Nationwide Children's Hospital | 2012-07-01 |
| Clinical Study With Blinatumomab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT01741792) | Amgen Research (Munich) GmbH | 2012-07-01 |
| Trial of Eltrombopag During Consolidation Therapy in Adults With AML in Complete Remission (NCT01656252) | PrECOG, LLC. | 2012-07-01 |
| Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab (NCT01730677) | National Cancer Center, Korea | 2012-07-01 |
| Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma (NCT01739244) | Sylentis, S.A. | 2012-07-01 |
| BE STUDY OF METFORMIN GSK 1000mg (NCT01710553) | GlaxoSmithKline | 2012-07-01 |
| VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C (NCT01581138) | Vertex Pharmaceuticals Incorporated | 2012-07-01 |
| A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00 (NCT01903018) | Piramal Enterprises Limited | 2012-07-01 |
| Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder (NCT01585207) | Barbara J. Coffey | 2012-07-01 |
| A Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Painful Diabetic Neuropathy (NCT01633086) | China Medical University Hospital | 2012-07-01 |
| Randomized Trial for Pain Management in Low-grade Subarachnoid Hemorrhage (NCT01851720) | Johns Hopkins University | 2012-07-01 |
| PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer (NCT02067416) | Jenny C. Chang, MD | 2012-07-01 |
| Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids (NCT01603277) | Humanigen, Inc. | 2012-07-01 |
| Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans (NCT01600703) | University Health Network, Toronto | 2012-07-01 |
| Integration of (iSBIRT) for Teen Drug Use Into a Pediatric Network (NCT01454206) | Boston Children's Hospital | 2012-07-01 |
| Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma (NCT02853370) | International Extranodal Lymphoma Study Group (IELSG) | 2012-07-01 |
| TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer (NCT01682772) | Institute of Cancer Research, United Kingdom | 2012-07-01 |
| Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI (NCT01398969) | McMaster University | 2012-07-01 |
| Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities (NCT01431105) | University of California, San Diego | 2012-07-01 |
| Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO Pilot (NCT01648036) | University of Manitoba | 2012-07-01 |
| Role of Intraperitoneal Intraoperative Chemotherapy With Paclitaxel in the Surgical Treatment of Peritoneal Carcinomatosis From Ovarian Cancer. Hyperthermia Versus Normothermia (NCT02739698) | Maimónides Biomedical Research Institute of Córdoba | 2012-07-01 |
| A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT (NCT01639261) | University Hospital Regensburg | 2012-07-01 |
| Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients (NCT01909830) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2012-07-01 |
| A Phase II Trial of PF-00299804 in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of Esophagus (NCT01608022) | Yonsei University | 2012-07-01 |
| Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma (NCT01652976) | University of Florida | 2012-07-01 |
| Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin (NCT01592240) | Pfizer | 2012-07-01 |
| Compliance to ERAS After Gastric Surgery (NCT01653496) | Chonnam National University Hospital | 2012-07-01 |
| Mesalazine Effects in Sporadic Colorectal Adenoma Patients (NCT01894685) | UMC Utrecht | 2012-07-01 |
| MISurf Versus InSurE. A Comparison of Minimally Invasive Surfactant Application Techniques in Preterm Infants (NCT01615016) | Hamilton Health Sciences Corporation | 2012-07-01 |
| Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach (NCT01611857) | SCRI Development Innovations, LLC | 2012-07-01 |
| Comparison of the Effect of Two Treatments on the Nutritional and Micronutrient Status of Malnourished Children (NCT01643187) | Association for the Study and Prevention of HIV/AIDS | 2012-07-01 |
| Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction (NCT01466270) | Wake Forest University Health Sciences | 2012-07-01 |
| A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy (NCT01597739) | Janssen Research & Development, LLC | 2012-07-01 |
| Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation (NCT01687257) | Gilead Sciences | 2012-07-01 |
| Safety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung Cancer (NCT01471197) | Bristol-Myers Squibb | 2012-07-01 |
| Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents (NCT01642615) | Takeda | 2012-07-01 |
| Prevention of Metabolic Complications of Glucocorticoid Excess (NCT01319994) | Barts & The London NHS Trust | 2012-07-01 |
| Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer (NCT01654185) | Xichun Hu | 2012-07-01 |
| Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery (NCT01655641) | Tribhuvan University Teaching Hospital, Institute Of Medicine. | 2012-07-01 |
| A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma (NCT01591044) | Rigel Pharmaceuticals | 2012-07-01 |
| The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris (NCT01768013) | LEO Pharma | 2012-07-01 |
| Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents (NCT01642602) | Takeda | 2012-07-01 |
| Low Dose Ketamine VR Analgesia During Burn Care Procedure (NCT01889537) | National Institute of General Medical Sciences (NIGMS) | 2012-07-01 |
| Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum Contagiosum (NCT02665260) | Montefiore Medical Center | 2012-07-01 |
| The Use of D-Cycloserine to Augment CBT for Pediatric OCD (NCT01687140) | University of California, Los Angeles | 2012-07-01 |
| Safety Study of GNbAC1 in Multiple Sclerosis Patients (NCT01639300) | GeNeuro Innovation SAS | 2012-07-01 |
| Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (NCT01504659) | Juvenile Bipolar Research Foundation | 2012-07-01 |
| Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM (NCT01526694) | Azienda Ospedaliera di Bolzano | 2012-07-01 |
| A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy (NCT01610492) | GlaxoSmithKline | 2012-07-01 |
| A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying (NCT01602549) | GlaxoSmithKline | 2012-07-01 |
| Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria (NCT01642979) | Institute of Hematology & Blood Diseases Hospital, China | 2012-07-01 |
| Effect of Testosterone Treatment on Embryo Quality (NCT01662466) | Center for Human Reproduction | 2012-07-01 |
| Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study (NCT01823887) | Cyberonics, Inc. | 2012-07-01 |
| A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor Treatment (NCT01579019) | Hoffmann-La Roche | 2012-07-01 |
| An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer (NCT01677455) | Synta Pharmaceuticals Corp. | 2012-07-01 |
| Injection Laryngoplasty Using Autologous Fat Enriched With Adipose Derived Regenerative Stem Cells (ADRC) (NCT02904824) | Hospital General Universitario Gregorio Marañon | 2012-07-01 |
| Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL (NCT01612988) | French Innovative Leukemia Organisation | 2012-07-01 |
| Effects of Mode of Administration of Soluble Fibre Blend on Glycemia, Appetite & Sensory Parameters (NCT01657058) | Unity Health Toronto | 2012-07-01 |
| Safety, Tolerability, and PK of AN2728 in Adolescents With Atopic Dermatitis (NCT01652885) | Pfizer | 2012-07-01 |
| Study to Evaluate the Safety and Activity of BB3 to Treat Heart Attack (NCT01539590) | Angion Biomedica Corp | 2012-07-01 |
| The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma (NCT01655888) | Azienda Ospedaliera Universitaria Senese | 2012-07-01 |
| Citriodiol® and Impetigo (NCT01611909) | Royal North Shore Hospital | 2012-07-01 |
| Dose-finding Adaptive Phase I/IIa Study to Assess Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of IPP-204106N on Advanced Solid Tumors (NCT01711398) | Elro Pharma | 2012-07-01 |
| Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy (NCT01625741) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2012-07-01 |
| Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris (NCT01628549) | Almirall, S.A. | 2012-06-30 |
| A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma (NCT01632228) | Hoffmann-La Roche | 2012-06-29 |
| A Study of LY2951742 in Participants With Migraine (NCT01625988) | Eli Lilly and Company | 2012-06-28 |
| A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression (NCT01640080) | Janssen Research & Development, LLC | 2012-06-27 |
| A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT01546038) | Pfizer | 2012-06-27 |
| Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors (NCT01602666) | Children's Oncology Group | 2012-06-27 |
| IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients (NCT01398085) | University College, London | 2012-06-26 |
| A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma (NCT01486368) | NCIC Clinical Trials Group | 2012-06-26 |
| Autologous Stem Cell Transplantation for Crohn's Disease (NCT00692939) | Paul Szabolcs | 2012-06-26 |
| Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma (NCT01615029) | Janssen Research & Development, LLC | 2012-06-26 |
| Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome (NCT01624805) | M.D. Anderson Cancer Center | 2012-06-25 |
| Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism (NCT01439867) | Amgen | 2012-06-22 |
| Canakinumab for Treatment of Adult-onset Still's Disease (NCT02204293) | Charite University, Berlin, Germany | 2012-06-21 |
| Dose Range Study of CD5789 in Acne Vulgaris (NCT01616654) | Galderma R&D | 2012-06-20 |
| A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis (NCT01565655) | Astellas Pharma Global Development, Inc. | 2012-06-19 |
| Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer (NCT01463072) | City of Hope Medical Center | 2012-06-19 |
| Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM) (NCT01587144) | Spectrum Pharmaceuticals, Inc | 2012-06-19 |
| Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma (NCT01614795) | National Cancer Institute (NCI) | 2012-06-18 |
| Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) (NCT01591863) | Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-06-15 |
| A Study of Selumetinib in Patients With Kaposi's Sarcoma (NCT01752569) | Sheffield Teaching Hospitals NHS Foundation Trust | 2012-06-15 |
| A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer (NCT01616303) | Quest PharmaTech Inc. | 2012-06-15 |
| Therapy De-escalation in Seminoma Stage IIA/B (NCT01593241) | Swiss Cancer Institute | 2012-06-15 |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas (NCT01560949) | M.D. Anderson Cancer Center | 2012-06-14 |
| A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer (NCT01525589) | PharmaMar | 2012-06-13 |
| PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery (NCT01515787) | Alliance for Clinical Trials in Oncology | 2012-06-12 |
| An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357) (NCT01498445) | M.D. Anderson Cancer Center | 2012-06-12 |
| BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma (NCT01512251) | University of California, San Francisco | 2012-06-09 |
| Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma (NCT01579318) | OncoSec Medical Incorporated | 2012-06-08 |
| A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer (NCT01756638) | Janssen Research & Development, LLC | 2012-06-06 |
| Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors (NCT01609790) | National Cancer Institute (NCI) | 2012-06-04 |
| Sorafenib VS TACE in HCC Patients With Portal Vein Invasion (NCT01480817) | Seoul National University Hospital | 2012-06-01 |
| Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders (NCT01624142) | Amgen | 2012-06-01 |
| Study on Autologous Osteoblastic Cells Implantation in Hypotrophic Non-Union Fractures (NCT01756326) | Bone Therapeutics S.A | 2012-06-01 |
| Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus (NCT01715935) | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 2012-06-01 |